Rick Doblin, Ph.D., is the Founder in 1986 and President of the Multidisciplinary Association for Psychedelic Studies (MAPS), a nonprofit that wholly owns its pharmaceutical arm, MAPS Public Benefit Corporation (PBC), which has completed two highly successful Phase 3 studies of MDMA-assisted therapy for PTSD. MAPS PBC stands at a crossroads between obtaining the additional resources it needs from philanthropy, ensuring public benefit is foremost, or becoming a publicly traded company.
A BetaSeries é a aplicação de referência para os fãs de séries que assistem a plataformas de streaming. Descarregue a aplicação gratuitamente, preencha a série que desejar, e receba recomendações instantâneas.
© 2024 BetaSeries - Todos os conteúdos externos continuam a ser propriedade do seu legítimo proprietário.